314 related articles for article (PubMed ID: 32265299)
1. High cell density increases glioblastoma cell viability under glucose deprivation via degradation of the cystine/glutamate transporter xCT (SLC7A11).
Yamaguchi I; Yoshimura SH; Katoh H
J Biol Chem; 2020 May; 295(20):6936-6945. PubMed ID: 32265299
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor promotes glioblastoma cell death under glucose deprivation via upregulation of xCT (SLC7A11).
Yamamoto M; Teramoto K; Katoh H
Cell Signal; 2021 Feb; 78():109874. PubMed ID: 33285240
[TBL] [Abstract][Full Text] [Related]
3. Merlin/NF2 regulates SLC7A11/xCT expression and cell viability under glucose deprivation at high cell density in glioblastoma cells.
Yamaguchi I; Katoh H
J Biochem; 2024 Mar; 175(3):313-322. PubMed ID: 38102738
[TBL] [Abstract][Full Text] [Related]
4. The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate.
Koppula P; Zhang Y; Shi J; Li W; Gan B
J Biol Chem; 2017 Aug; 292(34):14240-14249. PubMed ID: 28630042
[TBL] [Abstract][Full Text] [Related]
5. ROS Mediate xCT-Dependent Cell Death in Human Breast Cancer Cells under Glucose Deprivation.
Chen MC; Hsu LL; Wang SF; Hsu CY; Lee HC; Tseng LM
Cells; 2020 Jul; 9(7):. PubMed ID: 32630312
[TBL] [Abstract][Full Text] [Related]
6. A synthetic lethal drug combination mimics glucose deprivation-induced cancer cell death in the presence of glucose.
Joly JH; Delfarah A; Phung PS; Parrish S; Graham NA
J Biol Chem; 2020 Jan; 295(5):1350-1365. PubMed ID: 31914417
[TBL] [Abstract][Full Text] [Related]
7. Cystine uptake through the cystine/glutamate antiporter xCT triggers glioblastoma cell death under glucose deprivation.
Goji T; Takahara K; Negishi M; Katoh H
J Biol Chem; 2017 Dec; 292(48):19721-19732. PubMed ID: 29038291
[TBL] [Abstract][Full Text] [Related]
8. The cystine/glutamate antiporter xCT is a key regulator of EphA2 S897 phosphorylation under glucose-limited conditions.
Teramoto K; Katoh H
Cell Signal; 2019 Oct; 62():109329. PubMed ID: 31152846
[TBL] [Abstract][Full Text] [Related]
9. xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain.
Ungard RG; Linher-Melville K; Nashed MG; Sharma M; Wen J; Singh G
Mol Pain; 2019; 15():1744806918822185. PubMed ID: 30799686
[TBL] [Abstract][Full Text] [Related]
10. Redox-dependent AMPK inactivation disrupts metabolic adaptation to glucose starvation in xCT-overexpressing cancer cells.
Lee Y; Itahana Y; Ong CC; Itahana K
J Cell Sci; 2022 Aug; 135(15):. PubMed ID: 35775474
[TBL] [Abstract][Full Text] [Related]
11. Cystine-glutamate antiporter xCT as a therapeutic target for cancer.
Liu L; Liu R; Liu Y; Li G; Chen Q; Liu X; Ma S
Cell Biochem Funct; 2021 Mar; 39(2):174-179. PubMed ID: 32749001
[TBL] [Abstract][Full Text] [Related]
12. Cystine and glutamate transport in renal epithelial cells transfected with human system x(-) (c).
Bridges CC; Zalups RK
Kidney Int; 2005 Aug; 68(2):653-64. PubMed ID: 16014042
[TBL] [Abstract][Full Text] [Related]
13. SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties.
Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Aboody KS
Stem Cells Dev; 2017 Sep; 26(17):1236-1246. PubMed ID: 28610554
[TBL] [Abstract][Full Text] [Related]
14. Consensus mutagenesis approach improves the thermal stability of system x
Oda K; Lee Y; Wiriyasermkul P; Tanaka Y; Takemoto M; Yamashita K; Nagamori S; Nishizawa T; Nureki O
Protein Sci; 2020 Dec; 29(12):2398-2407. PubMed ID: 33016372
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional control of cystine/glutamate transporter gene by amino acid deprivation.
Sato H; Nomura S; Maebara K; Sato K; Tamba M; Bannai S
Biochem Biophys Res Commun; 2004 Dec; 325(1):109-16. PubMed ID: 15522208
[TBL] [Abstract][Full Text] [Related]
16. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
Koppula P; Zhuang L; Gan B
Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412
[TBL] [Abstract][Full Text] [Related]
17. Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/beta-catenin pathway.
Chen RS; Song YM; Zhou ZY; Tong T; Li Y; Fu M; Guo XL; Dong LJ; He X; Qiao HX; Zhan QM; Li W
Oncogene; 2009 Jan; 28(4):599-609. PubMed ID: 19015640
[TBL] [Abstract][Full Text] [Related]
18. Rotavirus-induced lncRNA SLC7A11-AS1 promotes ferroptosis by targeting cystine/glutamate antiporter xCT (SLC7A11) to facilitate virus infection.
Banerjee S; Sarkar R; Mukherjee A; Mitra S; Gope A; Chawla-Sarkar M
Virus Res; 2024 Jan; 339():199261. PubMed ID: 37923170
[TBL] [Abstract][Full Text] [Related]
19. Increased Expression of System xc- in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance.
Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Cassady K; Aboody KS
Mol Cancer Res; 2016 Dec; 14(12):1229-1242. PubMed ID: 27658422
[TBL] [Abstract][Full Text] [Related]
20. Glial Glutamate Transporter-Mediated Plasticity: System x
Dahlmanns M; Dahlmanns JK; Savaskan N; Steiner HH; Yakubov E
Front Biosci (Landmark Ed); 2023 Mar; 28(3):57. PubMed ID: 37005761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
